Skip to main
SGHT
SGHT logo

Sight Sciences (SGHT) Stock Forecast & Price Target

Sight Sciences (SGHT) Analyst Ratings

Based on 7 analyst ratings
Hold
Strong Buy 29%
Buy 0%
Hold 57%
Sell 14%
Strong Sell 0%

Bulls say

Sight Sciences Inc. demonstrated strong financial performance with a gross margin of 86.8%, reflecting a year-over-year increase of 160 basis points, surpassing the consensus estimate of 86.2%. The company also reported an increase in ordering facilities, rising to 1,138, indicating growth momentum in its operational reach. Moreover, potential upside drivers such as accelerated revenue growth from market share gains in the minimally invasive glaucoma surgery (MIGS) market, faster adoption of the TearCare system, and progress toward profitability contribute to a positive outlook for the company's future.

Bears say

The financial analysis indicates a negative outlook for Sight Sciences due to significant underperformance in the Dry Eye segment, which reported revenue of $0.3 million, missing consensus estimates of $0.4 million, and declining by 84% year-over-year. Additionally, the company’s decision to shift the TearCare product to reimbursed procedures has resulted in anticipated revenue decline and headwinds in future growth, as reflected in lowered GAAP EPS estimates for both 2025 and 2026. Furthermore, the recent implementation of Local Coverage Determinations (LCDs) negatively impacted the utilization of the OMNI Surgical System, contributing to the expectation of low- to mid-double-digit percentage revenue declines in the first quarter of 2025.

Sight Sciences (SGHT) has been analyzed by 7 analysts, with a consensus rating of Hold. 29% of analysts recommend a Strong Buy, 0% recommend Buy, 57% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sight Sciences and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sight Sciences (SGHT) Forecast

Analysts have given Sight Sciences (SGHT) a Hold based on their latest research and market trends.

According to 7 analysts, Sight Sciences (SGHT) has a Hold consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4.09, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4.09, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sight Sciences (SGHT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.